Julia K. Mader

6.0k total citations
165 papers, 2.5k citations indexed

About

Julia K. Mader is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Julia K. Mader has authored 165 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Endocrinology, Diabetes and Metabolism, 66 papers in Surgery and 57 papers in Genetics. Recurrent topics in Julia K. Mader's work include Diabetes Management and Research (123 papers), Pancreatic function and diabetes (62 papers) and Diabetes and associated disorders (57 papers). Julia K. Mader is often cited by papers focused on Diabetes Management and Research (123 papers), Pancreatic function and diabetes (62 papers) and Diabetes and associated disorders (57 papers). Julia K. Mader collaborates with scholars based in Austria, Germany and United Kingdom. Julia K. Mader's co-authors include Thomas R. Pieber, Felix Aberer, Roman Hovorka, Gerlies Treiber, Dimas Ikeoka, Hood Thabit, Harald Sourij, Mark L. Evans, Johannes Plank and Martin Ellmerer and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Julia K. Mader

147 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia K. Mader Austria 28 1.7k 1.0k 832 249 224 165 2.5k
John Shin United States 27 2.4k 1.4× 1.9k 1.8× 1.5k 1.8× 81 0.3× 150 0.7× 98 3.2k
Lia Bally Switzerland 26 1.2k 0.7× 684 0.7× 537 0.6× 59 0.2× 242 1.1× 122 2.0k
Tomasz Klupa Poland 27 1.4k 0.8× 1.1k 1.1× 1.1k 1.3× 213 0.9× 559 2.5× 133 2.5k
Ernesto Maddaloni Italy 26 953 0.6× 616 0.6× 643 0.8× 147 0.6× 403 1.8× 95 2.1k
Silvia Manfrini Italy 35 1.2k 0.7× 964 1.0× 637 0.8× 433 1.7× 481 2.1× 104 3.4k
Jan Schulze Germany 20 1.4k 0.8× 428 0.4× 374 0.4× 129 0.5× 591 2.6× 69 2.3k
G. Alexander Fleming United States 15 1.6k 0.9× 787 0.8× 733 0.9× 42 0.2× 480 2.1× 30 2.5k
David N. O’Neal Australia 26 1.8k 1.0× 979 1.0× 734 0.9× 41 0.2× 275 1.2× 172 3.1k
W. Garry John United Kingdom 24 1.5k 0.9× 271 0.3× 341 0.4× 143 0.6× 424 1.9× 50 2.5k
Jeremy Pettus United States 28 2.2k 1.3× 1.5k 1.5× 1.1k 1.4× 32 0.1× 385 1.7× 74 2.9k

Countries citing papers authored by Julia K. Mader

Since Specialization
Citations

This map shows the geographic impact of Julia K. Mader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia K. Mader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia K. Mader more than expected).

Fields of papers citing papers by Julia K. Mader

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia K. Mader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia K. Mader. The network helps show where Julia K. Mader may publish in the future.

Co-authorship network of co-authors of Julia K. Mader

This figure shows the co-authorship network connecting the top 25 collaborators of Julia K. Mader. A scholar is included among the top collaborators of Julia K. Mader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia K. Mader. Julia K. Mader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mader, Julia K., Ahmed Hassoun, Lutz Heinemann, et al.. (2025). Existing Knowledge Gaps in Risk Factors and Consequences of Lipohypertrophy in People Using Continuous Subcutaneous Insulin Infusion Therapy: A Systematic Review and Meta-analysis. Journal of Diabetes Science and Technology. 580929022–580929022. 1 indexed citations
3.
Klonoff, David C., Lori Berard, Denise Reis Franco, et al.. (2025). Advance Insulin Injection Technique and Education With FITTER Forward Expert Recommendations. Mayo Clinic Proceedings. 100(4). 682–699. 1 indexed citations
4.
Wilmot, Emma G., Ketan Dhatariya, Hood Thabit, et al.. (2025). Implementation Strategies for Inpatient Continuous Glucose Monitoring-based Diabetes Management: A Systematic Review. The Journal of Clinical Endocrinology & Metabolism. 110(7). e2411–e2419. 4 indexed citations
5.
Mader, Julia K., Ahmed Hassoun, Lutz Heinemann, et al.. (2025). Risk factors for Lipohypertrophy in People With Insulin-Treated Diabetes: A Systematic Meta-Analysis. Journal of Diabetes Science and Technology. 580934785–580934785. 2 indexed citations
6.
Adolfsson, Peter, Bruno Guerci, Niels Væver Hartvig, et al.. (2025). Glycaemic control after connected insulin pen initiation in people living with diabetes: Results from a real‐world setting. Diabetes Obesity and Metabolism. 27(11). 6507–6515. 1 indexed citations
7.
8.
Boughton, Charlotte K., Munachiso Nwokolo, Sara Hartnell, et al.. (2024). Impact of Ultra-Rapid Insulin on Boost and Ease-Off in the Cambridge Hybrid Closed-Loop System for Individuals With Type 1 Diabetes. Journal of Diabetes Science and Technology. 20(2). 381–387. 1 indexed citations
9.
Tittel, Sascha R., Alena Welters, Wölfram Karges, et al.. (2024). Increased cardiovascular risk in people with LADA in comparison to type 1 diabetes and type 2 diabetes: Findings from the DPV registry in Germany and Austria. Diabetes Obesity and Metabolism. 27(2). 563–573. 1 indexed citations
10.
Haliloğlu, Belma, Charlotte K. Boughton, Julia Ware, et al.. (2024). Postprandial Glucose Excursions with Ultra-Rapid Insulin Analogs in Hybrid Closed-Loop Therapy for Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics. 26(7). 449–456. 5 indexed citations
11.
Mader, Julia K., Delia Waldenmaier, Gerhard Vogt, et al.. (2024). Performance of a Novel Continuous Glucose Monitoring Device in People With Diabetes. Journal of Diabetes Science and Technology. 18(5). 1044–1051. 6 indexed citations
12.
13.
Mader, Julia K., et al.. (2024). 1924-LB: Clinical Performance of a Novel CGM System. Diabetes. 73(Supplement_1).
14.
Mader, Julia K., et al.. (2023). Matrix metalloproteinase sensing in wound fluids: Are graphene-based field effect transistors a viable alternative?. Biosensors and Bioelectronics X. 13. 100305–100305. 7 indexed citations
15.
Hanes, Sarah J., Charlotte K. Boughton, Sara Hartnell, et al.. (2023). Patient‐reported outcomes for older adults on CamAPS FX closed loop system. Diabetic Medicine. 40(9). e15126–e15126. 8 indexed citations
16.
Jendle, Johan, Peter Adolfsson, Pratik Choudhary, et al.. (2023). A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective. Diabetologia. 67(2). 236–245. 14 indexed citations
17.
Ruan, Yue, Lia Bally, Hood Thabit, et al.. (2018). Hypoglycaemia incidence and recovery during home use of hybrid closed‐loop insulin delivery in adults with type 1 diabetes. Diabetes Obesity and Metabolism. 20(8). 2004–2008. 18 indexed citations
18.
Ruan, Yue, Hood Thabit, Lalantha Leelarathna, et al.. (2017). Faster insulin action is associated with improved glycaemic outcomes during closed‐loop insulin delivery and sensor‐augmented pump therapy in adults with type 1 diabetes. Diabetes Obesity and Metabolism. 19(10). 1485–1489. 8 indexed citations
19.
Bally, Lia, Hood Thabit, Yue Ruan, et al.. (2017). Bolusing frequency and amount impacts glucose control during hybrid closed‐loop. Diabetic Medicine. 35(3). 347–351. 9 indexed citations
20.
Theiler‐Schwetz, Verena, Christian Trummer, Claudia Friedl, et al.. (2017). Visceral leishmaniasis in a patient with diabetes mellitus type 2 and discrete bicytopenia. Clinical Case Reports. 6(1). 78–81. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Shin Breakdown of academic impact, for papers by Lia Bally Breakdown of academic impact, for papers by Tomasz Klupa Breakdown of academic impact, for papers by Ernesto Maddaloni Breakdown of academic impact, for papers by Silvia Manfrini Breakdown of academic impact, for papers by Jan Schulze Breakdown of academic impact, for papers by G. Alexander Fleming Breakdown of academic impact, for papers by David N. O’Neal Breakdown of academic impact, for papers by W. Garry John Breakdown of academic impact, for papers by Jeremy Pettus
Rankless by CCL
2026